Apoptosis of infected cells is critically involved in antiviral defense. Apoptosis, however, may also support the release and spread of viruses. Although the elimination of infected hepatocytes is required to combat hepatitis B virus (HBV) infection, it is still unknown which consequences hepatocyte apoptosis has for the virus and whether or not it is advantageous to the virus. To study this, we designed a cell culture model consisting of both HBV-producing cell lines and primary human hepatocytes serving as an infection model. We showed that the release of mature, enveloped virions was 80% to 90% reduced 24 h after the induction of apoptosis in HBV-replicating hepatoma cells or HBV-infected hepatocytes. Importantly, HBV particles released from apoptotic hepatocytes were immature and nonenveloped and proved not to be infectious. We found an inverse correlation between the strength of an apoptotic stimulus and the infectivity of the virus particles released: the more potent the apoptotic stimulus, the higher the ratio of nonenveloped capsids to virions and the lower their infectivity. Furthermore, we demonstrated that HBV replication and, particularly, the expression of the HBx protein transcribed from the viral genome during replication do not sensitize cells to apoptosis. Our data clearly reject the hypothesis that the apoptosis of infected hepatocytes facilitates the propagation of HBV. Rather, these data indicate that HBV needs to prevent the apoptosis of its host hepatocyte to ensure the release of infectious progeny and, thus, virus spread in the liver.Human hepatitis B virus (HBV) is a small DNA virus characterized by a pronounced liver tropism. HBV replicates and assembles exclusively in hepatocytes without the need for cell disruption. Progeny viral particles are released through the secretory pathway. The "noncytopathic" behavior of HBV has been demonstrated with stably transfected hepatoma cell lines (32, 36) and with HBV-infected primary human hepatocytes (PHH) (35). The noncytopathic replication strategy explains why HBV infection per se does not cause liver damage in HBV-transgenic mice (14) or HBV carriers infected around birth and why it elicits little innate immune response (51). When the immune system becomes activated, however, inflammatory liver disease called hepatitis B becomes evident, and the infection may be cleared. Although HBV obviously does not need cell destruction to release infectious progeny, it is still debated whether HBV might sensitize the host hepatocyte to apoptosis to enhance its spread in the liver (41, 45).The viral genome (3.2 kb), consisting of a partially doublestranded, relaxed circular DNA (rcDNA), shows an extremely compact organization, with overlapping open reading frames and regulatory elements. Upon viral uptake into hepatocytes, the HBV capsid is transported to the nuclear pore complex, where the rcDNA genome is released into the nucleus. Inside the nucleus the rcDNA is converted to a covalently closed circular DNA (cccDNA) by cellular enzymes, which serves as ...